Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Jan-23 4:30 PM View:  | Hansen Paul R. Director | Vyant Bio, Inc. (VYNT) | 17-Jan-23 | Grant | 4,032 | -- | -- | 3% 148.96K to 153.0K | |
| 19-Jan-23 4:30 PM View: | Fletcher R John Director | Vyant Bio, Inc. (VYNT) | 17-Jan-23 | Grant | 4,368 | -- | -- | 17% 25.59K to 29.95K | |
| 19-Jan-23 4:30 PM View: | Horobin Joanna Director | Vyant Bio, Inc. (VYNT) | 17-Jan-23 | Grant | 7,526 | -- | -- | 48% 15.6K to 23.12K | |
| 19-Jan-23 4:30 PM View: | Harris Geoffrey E. Director | Vyant Bio, Inc. (VYNT) | 17-Jan-23 | Grant | 5,712 | -- | -- | 41% 14.05K to 19.76K | |
| 22-Nov-22 4:03 PM View: | Harris Geoffrey E. Director | Vyant Bio, Inc. (VYNT) | 18-Nov-22 | Market Sale | 765 | $1.33 | $1,021.11 | (5%) 14.78K to 14.02K | 9% |
| 19-Oct-22 9:00 AM View: | Fletcher R John Director | Vyant Bio, Inc. (VYNT) | 17-Oct-22 | Grant | 8,290 | -- | -- | 7% 119.66K to 127.95K | |
| 19-Oct-22 9:00 AM View: | Horobin Joanna Director | Vyant Bio, Inc. (VYNT) | 17-Oct-22 | Grant | 14,285 | -- | -- | 22% 63.71K to 77.99K | |
| 19-Oct-22 9:00 AM View: | Harris Geoffrey E. Director | Vyant Bio, Inc. (VYNT) | 17-Oct-22 | Grant | 10,841 | -- | -- | 17% 63.08K to 73.92K | |
| 19-Oct-22 9:00 AM View: | Hansen Paul R. Director | Vyant Bio, Inc. (VYNT) | 17-Oct-22 | Grant | 7,653 | -- | -- | 1% 737.17K to 744.83K | |
| 29-Jul-22 5:01 PM View: | Horobin Joanna Director | Vyant Bio, Inc. (VYNT) | 18-Jul-22 | Grant | 8,092 | -- | -- | 15% 55.62K to 63.71K | |
| 29-Jul-22 4:59 PM View: | Harris Geoffrey E. Director | Vyant Bio, Inc. (VYNT) | 18-Jul-22 | Grant | 6,141 | -- | -- | 11% 56.94K to 63.08K | |
| 29-Jul-22 4:54 PM View: | Hansen Paul R. Director | Vyant Bio, Inc. (VYNT) | 18-Jul-22 | Grant | 4,335 | -- | -- | < 1% 732.84K to 737.17K | |
| 29-Jul-22 4:56 PM View: | Fletcher R John Director | Vyant Bio, Inc. (VYNT) | 18-Jul-22 | Grant | 4,696 | -- | -- | 4% 114.96K to 119.66K | |
| 19-Apr-22 7:36 PM View: | Harris Geoffrey E. Director | Vyant Bio, Inc. (VYNT) | 18-Apr-22 | Grant | 5,157 | -- | -- | 10% 51.78K to 56.94K | |
| 19-Apr-22 7:40 PM View: | Horobin Joanna Director | Vyant Bio, Inc. (VYNT) | 18-Apr-22 | Grant | 6,796 | -- | -- | 14% 48.82K to 55.62K | |
| 19-Apr-22 7:36 PM View: | Fletcher R John Director | Vyant Bio, Inc. (VYNT) | 18-Apr-22 | Grant | 3,944 | -- | -- | 4% 111.02K to 114.96K | |
| 19-Apr-22 7:35 PM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 18-Apr-22 | Grant | 7,281 | -- | -- | 4% 177.99K to 185.27K | |
| 19-Apr-22 7:38 PM View: | Hansen Paul R. Director | Vyant Bio, Inc. (VYNT) | 18-Apr-22 | Grant | 3,640 | -- | -- | < 1% 729.2K to 732.84K | |
| 01-Apr-22 4:30 PM View: | McLeod Howard Director | Vyant Bio, Inc. (VYNT) | 30-Mar-22 | Grant | 43,478 | -- | -- | 9683% 0.45K to 43.93K | |
| 01-Apr-22 4:30 PM View: | Fletcher R John Director | Vyant Bio, Inc. (VYNT) | 30-Mar-22 | Grant | 43,478 | -- | -- | 102% 42.7K to 86.17K | |
| 01-Apr-22 4:30 PM View: | Yeh Yung-Ping Director | Vyant Bio, Inc. (VYNT) | 30-Mar-22 | Grant | 43,478 | -- | -- | 3% 1.33M to 1.37M | |
| 01-Apr-22 4:30 PM View: | Horobin Joanna Director | Vyant Bio, Inc. (VYNT) | 30-Mar-22 | Grant | 43,478 | -- | -- | 814% 5.34K to 48.82K | |
| 13-Apr-22 5:05 PM View: | Fletcher R John Director | Vyant Bio, Inc. (VYNT) | 30-Mar-22 | Grant | 24,844 | -- | -- | 29% 86.17K to 111.02K | |
| 01-Apr-22 4:30 PM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 30-Mar-22 | Grant | 43,478 | -- | -- | 32% 134.51K to 177.99K | |
| 01-Apr-22 4:30 PM View: | Hansen Paul R. Director | Vyant Bio, Inc. (VYNT) | 30-Mar-22 | Grant | 43,478 | -- | -- | 6% 685.72K to 729.2K | |
| 01-Apr-22 4:30 PM View: | Harris Geoffrey E. Director | Vyant Bio, Inc. (VYNT) | 30-Mar-22 | Grant | 43,478 | -- | -- | 524% 8.3K to 51.78K | |
| 20-Jan-22 9:22 PM View: | Horobin Joanna Director | Vyant Bio, Inc. (VYNT) | 18-Jan-22 | Grant | 5,343 | $1.31 | $6,999.33 | 100% 0 to 5.34K | (7%) |
| 20-Jan-22 9:20 PM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 18-Jan-22 | Grant | 5,725 | $1.31 | $7,499.75 | 4% 128.79K to 134.51K | (7%) |
| 20-Jan-22 9:19 PM View: | Hansen Paul R. Director | Vyant Bio, Inc. (VYNT) | 18-Jan-22 | Grant | 2,862 | $1.31 | $3,749.22 | < 1% 682.86K to 685.72K | (7%) |
| 20-Jan-22 9:23 PM View: | Harris Geoffrey E. Director | Vyant Bio, Inc. (VYNT) | 18-Jan-22 | Grant | 4,055 | $1.31 | $5,312.05 | 95% 4.25K to 8.3K | (7%) |
| 20-Jan-22 9:22 PM View: | Fletcher R John Director | Vyant Bio, Inc. (VYNT) | 18-Jan-22 | Grant | 3,721 | $1.31 | $4,874.51 | 10% 38.98K to 42.7K | (7%) |
| 07-Dec-21 9:00 AM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 06-Dec-21 | Market Purchase | 5,000 | $1.69 | $8,450.00 | 4% 123.79K to 128.79K | (4%) |
| 24-Nov-21 4:05 PM View: | Roberts John A Chief Executive Officer | Vyant Bio, Inc. (VYNT) | 24-Nov-21 | Market Purchase | 5,000 | $2.02 | $10,100.00 | 14% 34.81K to 39.81K | (1%) |
| 24-Nov-21 4:05 PM View: | Lafrence Andrew D.C. Chief Financial Officer | Vyant Bio, Inc. (VYNT) | 23-Nov-21 | Market Purchase | 5,000 | $2.00 | $9,997.50 | 8% 59.2K to 64.2K | (< 1%) |
| 23-Nov-21 7:51 PM View: | Yeh Yung-Ping Chief Innovation Officer Director | Vyant Bio, Inc. (VYNT) | 22-Nov-21 | Market Purchase | 500 | $2.05 | $1,025.00 | < 1% 1.33M to 1.33M | (1%) |
| 27-Feb-23 5:41 PM View: | Hansen Paul R. Director | Vyant Bio, Inc. (VYNT) | 09-Nov-21 | txn.W.title | 6,783 | -- | -- | 4% 153.0K to 159.78K | |
| 17-Nov-21 5:05 PM View: | Fremeau Robert Thomas Jr. Chief Scientific Officer | Vyant Bio, Inc. (VYNT) | 28-Oct-21 | Market Purchase | 1,000 | $2.19 | $2,190.00 | 100% 0 to 1.0K | (< 1%) |
| 28-Oct-21 4:30 PM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 27-Oct-21 | Market Purchase (Planned) | 5,000 | $2.10 | $10,500.00 | 4% 118.79K to 123.79K | (2%) |
| 30-Sep-21 8:45 AM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 29-Sep-21 | Market Purchase (Planned) | 5,000 | $2.44 | $12,200.00 | 4% 113.79K to 118.79K | (5%) |
| 27-Aug-21 8:45 AM View: | Yeh Yung-Ping Chief Innovation Officer Director | Vyant Bio, Inc. (VYNT) | 25-Aug-21 | Market Purchase | 1,000 | $2.64 | $2,640.00 | < 1% 1.33M to 1.33M | 1% |
| 26-Aug-21 8:45 AM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 25-Aug-21 | Market Purchase (Planned) | 5,000 | $2.58 | $12,878.00 | 5% 108.79K to 113.79K | (1%) |
| 25-Aug-21 5:03 PM View: | Roberts John A Chief Executive Officer | Vyant Bio, Inc. (VYNT) | 23-Aug-21 | Market Purchase | 10,406 | $2.41 | $25,078.50 | 43% 24.4K to 34.81K | 8% |
| 23-Aug-21 3:42 PM View: | Hansen Paul R. Director | Vyant Bio, Inc. (VYNT) | 19-Aug-21 | Market Purchase | 20,000 | $2.35 | $47,000.00 | 3% 662.86K to 682.86K | (< 1%) |
| 28-Jul-21 9:45 PM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 28-Jul-21 | Market Purchase (Planned) | 5,000 | $2.92 | $14,623.50 | 5% 103.79K to 108.79K | (3%) |
| 01-Jul-21 5:19 PM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 30-Jun-21 | Market Purchase (Planned) | 5,000 | $3.76 | $18,824.50 | 5% 98.93K to 103.93K | |
| 01-Jun-21 5:10 PM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 28-May-21 | Market Purchase (Planned) | 5,000 | $3.68 | $18,400.00 | 5% 93.93K to 98.93K | < 1% |
| 01-Jul-21 5:19 PM View: | Boehm Marcus Director | Vyant Bio, Inc. (VYNT) | 28-May-21 | Gift | 5,000 | -- | -- | (5%) 103.93K to 98.93K | |
| 27-May-21 5:31 PM View: | Roberts John A Chief Executive Officer | Vyant Bio, Inc. (VYNT) | 26-May-21 | Market Purchase | 7,041 | $3.55 | $24,995.50 | 2% 305.08K to 312.12K | < 1% |
| 27-May-21 5:31 PM View: | Roberts John A Chief Executive Officer | Vyant Bio, Inc. (VYNT) | 24-May-21 | Market Purchase | 7,440 | $3.38 | $25,147.20 | 2% 297.64K to 305.08K | 6% |
| 24-May-21 4:05 PM View: | Fletcher R John Director | Vyant Bio, Inc. (VYNT) | 24-May-21 | Market Purchase | 15,300 | $3.39 | $51,834.90 | 65% 23.68K to 38.98K |
